Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Daridorexant in Insomnia Disorder
NCT03545191Phase 3Completed
- Sponsor
- Idorsia
- Start
- Jun 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of daridorexant in insomnia disorder, sponsored by Idorsia. Started Jun 2018; status: completed.
02
Drugs
daridorexant
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT03545191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03545191.